Works by Carroll, Kevin J.
Results: 16
A practical guide to the appropriate analysis of eGFR data over time: A simulation study.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 5, p. 742, doi. 10.1002/pst.2381
- By:
- Publication type:
- Article
Conditional power and information fraction calculations at an interim analysis for random coefficient models.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 2, p. 276, doi. 10.1002/pst.2345
- By:
- Publication type:
- Article
Coping with missing data in phase III pivotal registration trials: Tolvaptan in subjects with kidney disease, a case study.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 4, p. 250, doi. 10.1002/pst.1808
- By:
- Publication type:
- Article
Back to basics: explaining sample size in outcome trials, are statisticians doing a thorough job?
- Published in:
- Pharmaceutical Statistics, 2009, v. 8, n. 4, p. 333, doi. 10.1002/pst.362
- By:
- Publication type:
- Article
Biomarkers in drug development: friend or foe? A personal reflection gained working within oncology.
- Published in:
- Pharmaceutical Statistics, 2007, v. 6, n. 4, p. 253, doi. 10.1002/pst.269
- By:
- Publication type:
- Article
Analysis of progression-free survival in oncology trials: some common statistical issues.
- Published in:
- Pharmaceutical Statistics, 2007, v. 6, n. 2, p. 99, doi. 10.1002/pst.251
- By:
- Publication type:
- Article
Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. Is there another way?
- Published in:
- Pharmaceutical Statistics, 2006, v. 5, n. 4, p. 283, doi. 10.1002/pst.218
- By:
- Publication type:
- Article
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparisons of global tests on intersection hypotheses and their application in matched parallel gatekeeping procedures.
- Published in:
- Journal of Biopharmaceutical Statistics, 2020, v. 30, n. 4, p. 593, doi. 10.1080/10543406.2019.1696355
- By:
- Publication type:
- Article
CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis.
- Published in:
- Clinical Kidney Journal, 2022, v. 15, n. 1, p. 136, doi. 10.1093/ckj/sfab117
- By:
- Publication type:
- Article
Subsequent urinary stone events are predicted by the magnitude of urinary oxalate excretion in enteric hyperoxaluria.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 12, p. 2208, doi. 10.1093/ndt/gfaa281
- By:
- Publication type:
- Article
Batch Selection via In Vitro/In Vivo Correlation in Pharmacokinetic Bioequivalence Testing.
- Published in:
- AAPS PharmSciTech, 2021, v. 22, n. 7, p. 1, doi. 10.1208/s12249-021-02064-0
- By:
- Publication type:
- Article
Performance of Multiple-Batch Approaches to Pharmacokinetic Bioequivalence Testing for Orally Inhaled Drug Products with Batch-to-Batch Variability.
- Published in:
- AAPS PharmSciTech, 2021, v. 22, n. 7, p. 1, doi. 10.1208/s12249-021-02063-1
- By:
- Publication type:
- Article
Batch‐to‐Batch and Within‐Subject Variability: What Do We Know and How Do These Variabilities Affect Clinical Pharmacology and Bioequivalence?
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 326, doi. 10.1002/cpt.1294
- By:
- Publication type:
- Article
Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis.
- Published in:
- Journal of Nephrology (JNonline), 2019, v. 32, n. 5, p. 811, doi. 10.1007/s40620-019-00631-0
- By:
- Publication type:
- Article